Journal of Substance Abuse Treatment
Volume 28, Issue 1 , Pages 1-2, January 2005

Medications work for severely addicted smokers: Implications for addiction therapists and primary care physicians☆☆☆

  • Jack E. Henningfield

      Affiliations

    • Johns Hopkins University School of Medicine and Pinney Associates, Inc., 3 Bethesda Metro Center, Suite 1400, Bethesda, MD 20814, USA
    • ,
  • A. Thomas McLellan

      Affiliations

    • Treatment Research Institute and University of Pennsylvania School of Medicine, 600 Public Ledger Boulevard, 150 S. Independence Mall, West Philadelphia, PA 19106, USA

Received 13 January 2005; received in revised form 13 January 2005; accepted 13 January 2005.

No abstract is available. To read the body of this article, please view the Full Text online.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

☆ The preparation of this commentary was supported by the Robert Wood Johnson Foundation Innovators Combating Substance Abuse Awards program at Johns Hopkins University School of Medicine.

☆☆ Dr. Henningfield provides consulting services regarding treatments for tobacco dependence to GlaxoSmithKline Consumer Health Care through Pinney Associates. He also has a financial interest in a nicotine replacement product under development, and serves as an expert witness in litigation against the tobacco industry by the United States. Dr. McLellan provides consulting services regarding treatments for opiate dependence to Purdue Pharma Inc. and regarding alcohol treatments to Alkermes Inc.

PII: S0740-5472(05)00017-6

doi:10.1016/j.jsat.2005.01.005

Journal of Substance Abuse Treatment
Volume 28, Issue 1 , Pages 1-2, January 2005

Article Tools